Scientific quality

Our scientific and advisory team

Dr. Efraín Olszewer

Specialist in Internal Medicine and Cardiology

Scientific Director and Honorary Member of SESAP and AMBO.
Scientific Director and Postgraduate Professor at FAPES and Clinical Director of the Centre for Preventive Medicine in São Paulo. Author of more than 73 books and numerous scientific publications.

Dr. Lucio Criado

Clinical Doctor

Professor with a Diploma in Diabetes and Metabolism and Pharmacy. Advisor in Pharmacology for the Spanish Society for Precision Health. Master’s Degree in Pharmaceutical Policy.

Dra. Alejandra Plaván

PhD in Medicine

Master’s Degree in Family and Community Medicine, Family Health, Neuropathic Sciences, Neural Therapy, Precision Health Medicine and Nutrition Training in Ultrasound, Auriculotherapy and Ozone Therapy.

Dr. Javier Martínez

PhD in Physiotherapy

Specialist in clinical biomechanics, movement analysis and sports physiotherapy. Professor at Cardenal Herrera CEU University. Director of the Villarreal CF – CEU Chair.

Virginia Santesteban

Pharmacy and Human Nutrition

Master’s Degree in Gut Microbiota
ISAK II Anthropometrist
Former nutritionist for Real Sociedad, Pachuca and CA Osasuna.
Independent nutrition consultant for sports performance.

Dra. María Trelis

PhD in Human and Animal Parasitology and Pharmacy

Professor of Parasitology and Nutrition at the University of Valencia. Researcher at the Endocrinology, Nutrition and Clinical Dietetics Research Unit at the La Fe University Hospital Research Institute.

Dr. José Miguel Soriano

Chair of Nutrition and Bromatology

Director of the Food & Health Lab. Institute of Materials Science. University of Valencia. Director of the University Clinic for Nutrition, Physical Activity and Physiotherapy at the Lluís Alcanyis Foundation.

Dr. Juan Gambini

Pharmacist and Physiologist

PhD in Pharmacy and Professor of Physiology at the Faculty of Medicine of the University of Valencia, he conducts research in the field of healthy ageing and nutrition.

R&D projects

At Overgenes, we actively participate in innovation and technological development projects focused on personalised medicine, digital health, and the multiscale integration of genetic, clinical, and lifestyle data. Below are some of the most relevant projects:

SPORT 5P

Reference: IMIDCA/2024/34
Entity: IVACE – R&D in Cooperation (PIDCOP-CV) 2024
Period: 22/02/2024 – 30/12/2025

5P Sports Technology for optimising physical performance and wellbeing.
The project combines genome, microbiome and physiological biosignals in a multiscale integration model that allows for the personalisation of training, recovery and nutrition plans for athletes and the active population.
Approach based on Predictive, Preventive, Personalised, Participatory and Precise (5P) medicine.

SENIOR HEALTH 6P

Reference: MIG-20241038
Entity: CDTi – Science and Innovation Missions Programme
Period: 09/2024 – 31/12/2025

Development of digital health solutions for healthy ageing through advanced biosanitary systems based on digital platforms.
The aim is to promote predictive and personalised models (6P) that integrate genetic, clinical, functional and environmental data to support prevention, diagnosis and treatment in the elderly population.

PHARMA PAIN 2.0

Reference: IMINOD2022/233
Entity: IVACE – INNOVATeiC-CV performance
Period: 01/03/2022 – 30/12/2023

Digitisation and automation of a pharmacogenetic test focused on chronic pain management, with the aim of improving therapeutic accuracy and personalising drug prescriptions. The project optimised processes in both genetic interpretation and clinical integration, reducing analysis times and facilitating medical decision-making.

NEOTEC - Innovative SME Seal

Reference: Program NEOTEC
Entity: Ministerio de Ciencia, Innovación y Universidades
Year of award: 2018

The NEOTEC programme grant enabled Overgenes to obtain the Innovative SME Seal, recognising the strength of its R&D strategy and its focus on personalised medicine.

With this funding, together with its own resources, it promoted continuous development in genetic technology applied to preventive healthcare.
A notable milestone in this process was Overgenes obtaining CE/IVD marking for the i3 test, making it the first preventive genetics test to be certified under this healthcare quality standard.

Commitment to Quality

At Overgenes, the quality and safety of our products and services are our top priority. That is why we adhere to rigorous international standards and maintain a firm commitment to scientific and health excellence:

Medical device manufacturer licence: We guarantee that all our development, production and marketing processes comply with the highest international quality standards.
Accreditation as importers of medical devices and biological samples: We ensure safety and full compliance with current regulations in every operation.
Implementation of ISO 13485: We are in the process of certifying our quality management system for medical devices, reinforcing the excellence and reliability of our processes.
CE-IVDR compliance: We are in the process of adapting and certifying our products in accordance with the European CE-IVDR Regulation, with a commitment to guaranteeing their safety, efficacy and traceability under the most demanding standards.